Kestra Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Sell
2,896
-493
-15% -$316K 0.01% 1431
2025
Q4
$2.29M Sell
3,389
-44
-1% -$30K 0.01% 1139
2025
Q3
$2.19M Sell
3,433
-14
-0.4% -$8.5K 0.01% 1096
2025
Q2
$1.85M Buy
3,447
+238
+7% +$114K 0.01% 1123
2025
Q1
$1.35M Buy
3,209
+304
+10% +$132K 0.01% 1201
2024
Q4
$1.2M Sell
2,905
-863
-23% -$379K 0.01% 1296
2024
Q3
$1.9M Sell
3,768
-24
-0.6% -$11.7K 0.01% 979
2024
Q2
$1.85M Buy
3,792
+1,481
+64% +$744K 0.01% 1001
2024
Q1
$1.25M Sell
2,311
-1,061
-31% -$580K 0.01% 1112
2023
Q4
$1.87M Sell
3,372
-51
-1% -$23.9K 0.02% 821
2023
Q3
$1.5M Sell
3,423
-655
-16% -$327K 0.01% 802
2023
Q2
$2.05M Buy
4,078
+1,144
+39% +$548K 0.02% 663
2023
Q1
$1.47M Sell
2,934
-2,536
-46% -$1.21M 0.02% 766
2022
Q4
$2.23M Buy
5,470
+1,845
+51% +$716K 0.02% 703
2022
Q3
$1.18M Sell
3,625
-1,269
-26% -$466K 0.01% 892
2022
Q2
$1.72M Buy
4,894
+1,763
+56% +$719K 0.02% 738
2022
Q1
$1.71M Sell
3,131
-294
-9% -$155K 0.02% 730
2021
Q4
$2.25M Buy
3,425
+554
+19% +$348K 0.02% 643
2021
Q3
$1.78M Sell
2,871
-1,025
-26% -$689K 0.02% 764
2021
Q2
$2.46M Buy
3,896
+175
+5% +$96.6K 0.03% 572
2021
Q1
$1.82M Buy
3,721
+264
+8% +$132K 0.02% 637
2020
Q4
$1.72M Buy
3,457
+3,437
+17,185% +$1.54M 0.02% 643
2020
Q3
$590K Buy
+20
New +$7.39K 0.01% 814

Other funds holding IDXX

Kestra Advisory Services's IDXX Position: Q1 2026 in Review

Kestra Advisory Services reduced its Idexx Laboratories (IDXX) stake by 15% in Q1 2026, selling an estimated $316K and leaving 2,896 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #1431.

Kestra Advisory Services first reported a position in IDXX in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.46M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Kestra Advisory Services held 2,896 shares of Idexx Laboratories worth $1.63M as of Q1 2026.
  • Kestra Advisory Services sold 493 Idexx Laboratories shares in Q1 2026, an estimated $316K.
  • Idexx Laboratories made up 0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #1431 holding.
  • Kestra Advisory Services first reported a position in Idexx Laboratories in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Idexx Laboratories position peaked at $2.46M in Q2 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.